Lucid Diagnostics Inc. Amortization of Intangible Assets
Lucid Diagnostics Inc. (LUCD) reported Amortization of Intangible Assets of $105.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-12
- Lucid Diagnostics Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $105.00K, a 0.00% change year-over-year.
- Lucid Diagnostics Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $105.00K, a 0.00% change year-over-year.
- Lucid Diagnostics Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $105.00K, a 0.94% decline year-over-year.
- Lucid Diagnostics Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $105.00K, a 0.00% change year-over-year.
- Lucid Diagnostics Inc. amortization of intangible assets for fiscal 2025 was $421.00K, a 38.81% decline from fiscal 2024.
- Lucid Diagnostics Inc. amortization of intangible assets for fiscal 2024 was $688.00K, a 65.96% decline from fiscal 2023.
- Lucid Diagnostics Inc. amortization of intangible assets for fiscal 2023 was $2.02M, a 22.56% increase from fiscal 2022.
- Lucid Diagnostics Inc. amortization of intangible assets for fiscal 2022 was $1.65M.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $105.00K 10-Q · filed 2026-08-12 | $210.00K 10-Q · filed 2026-08-12 | $315.00K derived: sum of 3 quarters · filed 2026-08-12 | $420.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $105.00K 10-Q · filed 2026-05-13 | $210.00K derived: sum of 2 quarters · filed 2026-05-13 | $315.00K derived: sum of 3 quarters · filed 2026-05-13 | $420.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $210.00K derived: sum of 2 quarters · filed 2026-03-25 | $315.00K derived: sum of 3 quarters · filed 2026-08-12 | $421.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $105.00K 10-Q · filed 2025-11-12 | $210.00K derived: sum of 2 quarters · filed 2026-08-12 | $316.00K 10-Q · filed 2025-11-12 | $421.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $105.00K 10-Q · filed 2026-08-12 | $210.00K 10-Q · filed 2026-08-12 | $316.00K derived: sum of 3 quarters · filed 2026-08-12 | $421.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $105.00K 10-Q · filed 2026-05-13 | $211.00K derived: sum of 2 quarters · filed 2026-05-13 | $316.00K derived: sum of 3 quarters · filed 2026-05-13 | $421.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $211.00K derived: sum of 2 quarters · filed 2026-03-25 | $316.00K derived: sum of 3 quarters · filed 2026-03-25 | $688.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $105.00K 10-Q · filed 2025-11-12 | $210.00K derived: sum of 2 quarters · filed 2025-11-12 | $582.00K 10-Q · filed 2025-11-12 | $1.09M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $105.00K 10-Q · filed 2025-08-12 | $477.00K 10-Q · filed 2025-08-12 | $982.00K derived: sum of 3 quarters · filed 2025-08-12 | $1.49M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $372.00K 10-Q · filed 2025-05-13 | $877.00K derived: sum of 2 quarters · filed 2025-05-13 | $1.38M derived: sum of 3 quarters · filed 2025-05-13 | $1.89M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.01M derived: sum of 2 quarters · filed 2025-03-24 | $1.51M derived: sum of 3 quarters · filed 2025-03-24 | $2.02M 10-K · filed 2025-03-24 |
| 2023-09-30 | $505.00K 10-Q · filed 2024-11-12 | $1.01M derived: sum of 2 quarters · filed 2024-11-12 | $1.52M 10-Q · filed 2024-11-12 | $2.02M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $505.00K 10-Q · filed 2024-08-12 | $1.01M 10-Q · filed 2024-08-12 | $1.51M derived: sum of 3 quarters · filed 2024-08-12 | $2.02M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $505.00K 10-Q · filed 2024-05-13 | $1.01M derived: sum of 2 quarters · filed 2024-05-13 | $1.51M derived: sum of 3 quarters · filed 2024-05-13 | $2.15M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.01M derived: sum of 2 quarters · filed 2024-03-25 | $1.65M derived: sum of 3 quarters · filed 2024-03-25 | $1.65M 10-K · filed 2024-03-25 |
| 2022-09-30 | $505.00K 10-Q · filed 2023-11-13 | $1.14M derived: sum of 2 quarters · filed 2023-11-13 | $1.14M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $639.00K 10-Q · filed 2023-08-14 | $639.00K 10-Q · filed 2023-08-14 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $0.00 derived: sum of 2 quarters · filed 2023-03-14 | $0.00 10-K · filed 2023-03-14 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |